SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005102
Filing Date
2020-05-05
Accepted
2020-05-05 08:11:14
Documents
95
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-20200331x10q.htm 10-Q 1890126
2 EX-10.1 xoma-20200331ex101e0821d.htm EX-10.1 723485
3 EX-10.2 xoma-20200331ex102070aa1.htm EX-10.2 31333
4 EX-31.1 xoma-20200331ex311ad1db8.htm EX-31.1 11209
5 EX-31.2 xoma-20200331ex312246155.htm EX-31.2 11251
6 EX-32.1 xoma-20200331ex321c5662f.htm EX-32.1 10068
  Complete submission text file 0001558370-20-005102.txt   8988748

Data Files

Seq Description Document Type Size
7 EX-101.INS xoma-20200331.xml EX-101.INS 1556731
8 EX-101.SCH xoma-20200331.xsd EX-101.SCH 88895
9 EX-101.CAL xoma-20200331_cal.xml EX-101.CAL 54768
10 EX-101.DEF xoma-20200331_def.xml EX-101.DEF 344316
11 EX-101.LAB xoma-20200331_lab.xml EX-101.LAB 555968
12 EX-101.PRE xoma-20200331_pre.xml EX-101.PRE 567149
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14710 | Film No.: 20846900
SIC: 2834 Pharmaceutical Preparations